Clinical Trial Update: Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating 3D radiotherapy with or without erlotinib in localized non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hospital of Navarra | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN